Welcome to our dedicated page for Visionary Holdings news (Ticker: GV), a resource for investors and traders seeking the latest updates and insights on Visionary Holdings stock.
Visionary Holdings Inc. (Nasdaq: GV) generates news at the intersection of education, health management, anti-aging medical aesthetics, and regenerative medicine. Company announcements describe an ongoing strategic transformation from a traditional education- and real estate-focused business toward a diversified platform centered on high-end medical aesthetics and big health technology, with AI-enabled education remaining as a supplementary division.
News coverage for GV includes updates on its fiscal year 2025 annual report, where the company outlined progress in its business restructuring and reported initial revenue contributions from emerging health-related businesses. Releases also detail Visionary Holdings' focus on health management initiatives, including gastrointestinal health management and early-stage commercialization efforts in Asia.
Another key stream of news relates to regenerative medicine and stem cell technology. Visionary Holdings has reported a Global Product and Technology Licensing Agreement with Jiangsu Yike Regenerative Medicine Co., Ltd., the creation of Visionary Yike Stemcell Technologies Inc. in Canada, and the launch of a stem cell-based anti-aging product line through its Visionary Health Technology Group Limited subsidiary. These items highlight the company’s emphasis on stem cell therapy, cellular rejuvenation, and premium anti-aging offerings in Asian markets.
Governance and compliance developments are also prominent in GV’s news. The company has announced board renewal, the formation of specialized committees, leadership changes, and auditor appointments, as well as a Nasdaq notification regarding a delayed Form 20-F filing and its plan to regain compliance. Additional releases describe Visionary Holdings’ controlling stake in a joint venture focused on Traditional Chinese Medicine health preservation.
Investors and observers reviewing GV news can expect updates on strategic partnerships, joint ventures, product launches in anti-aging and regenerative medicine, governance changes, and disclosures related to its education and health businesses.
Visionary Holdings (NASDAQ: GV) has announced its entry into the new energy vehicle market with the launch of its PEGASUS brand in 2025. The company plans to introduce two initial models: a compact electric sedan with 400-500km range and a luxury SUV with 500-600km range.
The company will implement a cross-ocean collaborative model, with vehicle development and assembly in Canada while leveraging global automotive parts suppliers. The production plan targets 100,000 vehicles in the first year with expected revenue of $4 billion. By year five, Visionary projects $15 billion in revenue with net profits of $1.5-2 billion.
Key features include solid-state battery technology enabling 10-80% charging in 10 minutes, 85% automation rate in production, and a 40% local parts sourcing target. The company plans to establish direct sales experience stores globally and implement an integrated online-offline sales strategy.
Visionary Holdings (GV) has demonstrated significant achievements in implementing generative AI across FinTech and biotechnology sectors. The company's AI solutions have delivered notable improvements in their digital asset trading platform, including a 40% reduction in transaction delays and a 97.5% fraud detection rate.
In their FinTech operations, AI implementation has reduced labor costs by 40% while increasing customer satisfaction to 94.2%. Their biotechnology division has achieved a 98.7% sensitivity rate in AI-driven cervical cancer E7 protein detection, earning FDA certification.
The company's AI system operates on a four-layer architecture: Intelligent Perception, Cognitive Decision, Generative Execution, and Autonomous Evolution, enabling comprehensive solutions across financial and medical applications. According to IDC, AI is projected to contribute $19.9 trillion to the global economy by 2030, representing 3.5% of global GDP.
Visionary Holdings (NASDAQ: GV) has announced significant strategic expansion in the new-energy vehicle industry through a partnership with Pegasus International Holding The company plans to list its new-energy vehicle project on the NASDAQ Main Board within 6-12 months, with a subsequent plan to list Pegasus International on the Hong Kong Stock Exchange in 3-5 years.
Pegasus International has placed an order for 12,000 new-energy vehicles (Hong Kong taxi version) at HK$145,800 per unit. The company is expanding into Hong Kong and Southeast Asian markets, focusing on new-energy light-truck market and battery-swapping/charging services. This expansion leverages regional government incentives and growing market demand for electric vehicles.
The company has transformed from traditional education and real estate to establish a diversified multinational framework incorporating four core businesses: technology, education, finance, and real estate.
Visionary Holdings (NASDAQ: GV) has issued a comprehensive response to address capital market concerns and highlight its development trajectory. The company, focused on precision medicine and biomedical innovation, reports that its R&D expenditure maintains at 15% of total expenditure, primarily directed towards early cancer screening research.
The company's financial structure remains stable, supported by cash reserves, institutional credit, and strategic investments. Their key developments include home detection technologies for cervical and colorectal cancer, currently in clinical trials with expected market launch within 18 months. These tests offer 15-minute results and focus on detecting precancerous lesions at lower costs.
GV plans to implement a dual B2B and B2C commercialization strategy, partnering with healthcare facilities while offering direct-to-consumer sales through online channels. Future expansion will be funded through diverse financing channels, including strategic investment and bond financing, with careful consideration to minimize shareholder dilution.
Visionary Holdings (NASDAQ: GV) is advancing in the precision medicine field, particularly in targeted therapy development. The company has made strategic investments in developing third-generation EGFR inhibitors for non-small cell lung cancer and partnered with gene sequencing companies for liquid biopsy technologies.
The company is leveraging AI-assisted drug development and has established collaborations with global biotech leaders to develop next-generation anticancer drugs targeting specific gene mutations like HER2, BRAF, and KRAS. Their clinical trial network spans North America, Europe, and Asia. They've also developed rapid at-home testing technologies for cervical and colorectal cancers.
According to McKinsey Global Institute, the global biopharmaceutical market is projected to exceed $1.5 trillion by 2030, with precision medicine expected to grow at a CAGR of over 10%.
Visionary Holdings Group (NASDAQ: GV) has established itself as a leader in technology and finance, focusing on artificial intelligence, digital finance, new energy, and biotechnology. The company's technological achievements include developing the VisionQ quantum computing chip and implementing AI systems in automotive manufacturing.
In digital finance, GV collaborates with regulatory agencies on CBDC projects and operates the VisionChain blockchain platform. The company's Pegasus New Energy Vehicle project plans to launch an electric sedan in North America by 2025, featuring solid-state battery technology and L4 autonomous driving.
GV has expanded globally through its Digital Technology Tower in North America, AI computing centers in the Middle East, and the SeaLLM language model in Southeast Asia. The company reported strong financial performance in 2024, driven by digital finance and EV sales, while committing to achieve 100% green energy usage for its data centers by 2025.
Visionary Holdings announced its successful business transformation at its 2024 Annual Conference in Toronto. The company has evolved from a traditional education provider into a diversified high-tech conglomerate, marking significant achievements including the OTC market listing of four subsidiaries: Pegasus New Energy Vehicles, SBS Green Energy, UBX FinTech, and American Precision Biotech.
Key developments include the launch of an at-home cancer self-testing product and Canada's first independently developed clean energy vehicle brand. The company plans to upgrade its subsidiaries' listings to Nasdaq in 2026. Visionary aims to position itself as a listed company accelerator platform, focusing on international cooperation, technological innovation, and shareholder value creation.
Visionary Holdings Inc. (NASDAQ: GV) has signed a Memorandum of Understanding (MOU) with the Public Investment Fund (PIF) of Saudi Arabia for an investment of up to USD 120 million. The partnership includes debt replacement for four of Visionary's commercial buildings and real estate redevelopment investment. PIF will provide financial, talent, and resource support for Visionary's global expansion, industrial upgrades, and debt optimization.
The collaboration extends to high technology, life sciences, and artificial intelligence education. Visionary, founded in 2013 and headquartered in Toronto, operates six schools in Canada and owns four commercial buildings valued at over CAD 120 million. The company holds over 100 patents and has subsidiaries in the US, Malaysia, and China. This partnership is expected to significantly boost Visionary's market value and industrial growth.
Visionary Holdings Inc. (NASDAQ: GV) has signed a Memorandum of Understanding (MOU) with the Public Investment Fund (PIF) of Saudi Arabia (Asia Division) on September 2, 2024. PIF, the world's largest sovereign wealth fund, will invest USD 120 million to support Visionary's various projects, including:
- Debt replacement for four commercial buildings
- Real estate redevelopment investment
- Global mergers and acquisitions
- Industrial upgrades
- Debt optimization
The partnership also includes collaboration in high technology, life sciences, and artificial intelligence education. Visionary, founded in August 2013 and headquartered in Toronto, operates six schools in Canada and owns four commercial and educational buildings valued at over CAD 120 million. The company focuses on mergers, acquisitions, and innovation in high technology, education, and life sciences sectors.
Visionary Holdings Inc. (NASDAQ:GV) reported its fiscal year 2024 financial results, showing revenue growth of 11.2% to $9.4 million. The company achieved a net income of $967,249, compared to a net loss of $3,572,108 in fiscal 2023. This improvement was primarily due to an $8.6 million gain on disposal of rental properties and a $1.9 million gain on fair value assessment of warrants and convertible notes. However, the gross margin decreased to 27.1% from 44.6% in the previous year. The company is undergoing a strategic transformation, shifting focus from traditional education to high technology, life sciences, and AI education. Visionary has made significant progress in AI robotics, biochips, and AI health sectors, with plans for product launches and expansion in these areas.